Gower Street
London, WC1E 6BT
United States
University College London - UCL Cancer Institute
deep learning, Self-supervised learning, Cell classification, Multiplex imaging, Multiplex Immunohistochemistry, Imaging mass cytometry, Biomarkers
ovarian cancer, Avelumab, PD-L1, Phase 3, immune checkpoint inhibitor
Placebo, adverse events, trial design, ovarian cancer, maintenance therapy, PARPi